The Best Herb in Singapore: Insights from Traditional Remedy to Modern Supplement

There is a particular kind of wisdom that does not arrive in peer-reviewed journals. It arrives instead in the weathered hands of a Malay bomoh preparing a root decoction before dawn, in the steaming claypot of a Cantonese sinseh's dispensary along Sago Lane, in the quiet ritual of a Tamil grandmother pressing dried tulsi leaves into warm water for a feverish grandchild.

Long before Singapore became a gleaming node of global biomedical research, before the Biopolis existed, before supplement brands competed for digital shelf space on Lazada, the people of this region had already developed a sophisticated, empirically derived pharmacopoeia drawn from the extraordinary botanical richness of the Southeast Asian rainforest and the ancient medical traditions that Southeast Asia absorbed, adapted, and made its own.

What is remarkable about this moment in Singapore's health and wellness landscape is not the proliferation of herbal supplements — that was always going to happen in a city-state of affluent, health-conscious, scientifically literate consumers. What is remarkable is the degree to which modern extraction science, clinical research methodology, and global market forces are now converging on the very same plants that regional healers identified centuries ago as exceptional.

The validation is moving in only one direction: from tradition toward confirmation, not the reverse. And for Singaporean consumers navigating an increasingly crowded and increasingly sophisticated supplement market, understanding that historical and scientific arc is the most reliable foundation for making genuinely informed choices.

The Botanical Heritage of a Region

Southeast Asia is, by any measure, one of the most biologically diverse regions on earth. The Sundaland biodiversity hotspot — encompassing the Malay Peninsula, Sumatra, Borneo, and Java — contains an estimated 25,000 plant species, of which a significant proportion have documented ethnobotanical use in traditional medicine systems.

The Malay traditional healing system, or perubatan Melayu, the Javanese jamu tradition, and the various indigenous healing systems of Borneo and Sulawesi collectively represent thousands of years of observational medicine — a vast, distributed clinical trial conducted without protocols, without placebos, but with a rigour born of consequence. Herbs that did not work were abandoned. Herbs that caused harm were avoided. Herbs that consistently produced beneficial outcomes were cultivated, traded, and passed down through generations with the kind of fidelity that only genuine utility sustains.

Singapore sits at the centre of this heritage, geographically and culturally. As a trading hub that drew migrants from across the Malay Archipelago, the Indian subcontinent, and China, the island city-state became a confluence of botanical traditions — Malay, Ayurvedic, and Traditional Chinese Medicine (TCM) — that coexist with unusual density in a small urban space.

The provision shops of Chinatown, the Indian medical halls of Little India, and the Malay herbal traders of Geylang are not anachronisms. They are living repositories of a pharmacological tradition that predates the pharmaceutical industry by millennia and is, in several important respects, still ahead of it in terms of understanding the body as an integrated system rather than a collection of isolated deficiencies.

Tongkat Ali: From Forest Floor to Global Stage

Of all the herbs to emerge from this rich Southeast Asian tradition into the global mainstream, none has made a more dramatic transition than Eurycoma longifolia — Tongkat Ali. Known in different parts of the region as pasak bumi in Indonesia, cây bá bệnh in Vietnam, and tho nan in Thailand, the plant has been used in traditional Malay medicine for centuries as a treatment for fatigue, fevers, sexual dysfunction, and general debility. Its vernacular name translates loosely as "Ali's walking stick," a colloquial reference to its traditional application as a male vitality tonic that speaks to the directness with which pre-modern healers named what they observed.

The modern scientific investigation of Tongkat Ali began in earnest in the 1990s, driven largely by Malaysian government-funded research through institutions including the Forest Research Institute Malaysia (FRIM) and Universiti Malaya. What researchers found was a root containing a biochemically complex array of quassinoids — most notably eurycomanone — along with eurypeptides and glycosaponins that collectively acted on the hypothalamic-pituitary-gonadal axis to support endogenous testosterone production, while simultaneously modulating the hypothalamic-pituitary-adrenal axis to reduce cortisol. The traditional healer's intuition about vitality restoration had, it turned out, a precise molecular basis.

The commercialisation of this research produced what is now the global standard for evidence-based Tongkat Ali supplementation: the Physta® extract, a standardised freeze-dried hot water extract developed through collaboration between Biotropics Malaysia and FRIM. Physta® has been the subject of multiple peer-reviewed randomised controlled trials — in stressed adults, in aging men and women, in physically active individuals — consistently demonstrating improvements in testosterone, cortisol modulation, mood, sexual function, and physical performance.

The 2013 Talbott et al. trial in the Journal of the International Society of Sports Nutrition reported a 16% reduction in salivary cortisol alongside a 37% increase in testosterone in moderately stressed adults taking 200 mg/day of Physta® for four weeks. The 2014 Henkel et al. study in Phytotherapy Research extended this to 400 mg/day in older active adults with significant testosterone and muscular-strength gains. The 2012 Tambi et al. paper in Andrologia reported testosterone restoration in men with late-onset hypogonadism on a standardised Physta® extract.

Physta® is, by any rigorous definition of the term, the most clinically validated botanical extract to emerge from Southeast Asia's traditional medicine heritage. That its origin lies in a Malay forest root known to village healers for centuries before any laboratory confirmed its mechanisms is a fact that deserves more prominent acknowledgement than it typically receives in the Western-dominated wellness media landscape.

Ginseng: The Ancient Standard-Bearer

No herb has a longer documented history of transition from traditional remedy to modern supplement than Panax ginseng — Korean or Asian ginseng — and its American cousin Panax quinquefolius. Used in Traditional Chinese Medicine for over 2,000 years, ginseng occupies a position in East Asian botanical heritage analogous to Tongkat Ali's in the Malay world: it is the herb against which all others are measured, the foundational tonic from which the very concept of adaptogenic medicine is culturally derived.

In Singapore, ginseng remains the dominant herbal supplement in the TCM retail sector, available in an extraordinary range of forms — from the prized red ginseng roots in lacquered gift boxes at Eu Yan Sang to standardised ginsenoside-rich capsules at every major pharmacy chain. Its bioactive ginsenosides have been the subject of thousands of published studies examining anti-fatigue effects, cognitive enhancement, immunomodulation, cardiovascular protection, and sexual function. The global ginseng market was valued at approximately USD 2.5 billion in 2022 and continues to grow, driven substantially by Asian diaspora communities and a growing Western consumer base drawn to its cognitive-enhancement evidence base.

For Singaporean men specifically, ginseng's strength lies in cognitive resilience, immune function, and the vascular mechanisms underpinning erectile health — the nitric oxide-mediated endothelial pathway that Korean red ginseng stimulates with well-documented clinical evidence. It is a different mechanism from Tongkat Ali's androgenic pathway, and the two are more complementary than competitive.

The Emergence of Ayurvedic Herbs in Singapore's Modern Market

The third major tradition contributing to Singapore's contemporary herbal supplement landscape is Ayurveda — the ancient Indian system of medicine that has produced, in the modern supplement era, a remarkably productive seam of clinically validated botanicals. Ashwagandha (Withania somnifera) and Shilajit are the two most prominent examples, and their rise in Singapore's supplement market over the past decade has been substantial.

Consider the trajectory of ashwagandha in particular. Haridas Pillai, a third-generation proprietor of a small Ayurvedic medicine hall in Little India, recounts that his grandfather sold dried ashwagandha root powder almost exclusively to the Indian community who knew it by name and purpose. Today, Haridas stocks four different branded ashwagandha supplement lines — KSM-66®, Sensoril®, and two generic standardised extracts — and his customer base is predominantly Chinese Singaporean professionals in their thirties and forties who discovered the herb through fitness podcasts and wellness social media.

"The plant has not changed," he observed in a recent interview. "What has changed is that people now have papers to show them what their bodies already knew was working."

His observation cuts to the heart of what modern extraction technology has accomplished for the traditional herbal medicine sector. The development of standardised proprietary extracts — defined by specific withanolide content for ashwagandha, ginsenoside ratios for ginseng, eurycomanone percentage for Tongkat Ali — has transformed inherently variable botanical raw materials into reproducible, clinically testable compounds. It is this standardisation that enabled the randomised controlled trials that validated traditional uses and simultaneously created the quality benchmarks that differentiate serious supplement brands from commodity raw material resellers.

Modern Extraction Technology and the Quality Revolution

The gap between a traditional decoction and a modern standardised extract is not merely one of convenience — it is a difference of pharmacological precision that has profound implications for both safety and efficacy. Traditional preparations were variable by nature: the concentration of bioactive compounds in a root depended on the plant's age, the soil composition, the seasonal conditions of harvest, and the preparation method. A bomoh's Tongkat Ali decoction might deliver a very different eurycomanone load from one batch to the next.

Modern supercritical CO₂ extraction, cryogenic freeze-drying, and hot water extraction under controlled parameters have eliminated that variability, producing extracts with defined, reproducible bioactive profiles that can be safety-tested, dose-calibrated, and subjected to the kind of double-blind clinical methodology that generates causal evidence rather than anecdote.

This technological development has not replaced traditional knowledge — it has amplified and authenticated it. The herbs that have performed best under modern scientific scrutiny are, almost without exception, the ones that traditional medicine systems had identified as most valuable centuries earlier. Tongkat Ali, ginseng, and ashwagandha are not successful modern supplements despite their traditional origins. They are successful in part because their traditional origins represented millennia of empirical selection pressure toward genuine efficacy.

A note on extract ratios

One side-effect of modern extract marketing deserves a frank word, because it cuts directly against the quality revolution this section celebrates. Tongkat Ali labels increasingly advertise extract ratios like 1:100 or 1:200, presented as if higher is better. The figure is largely jargon. A 1:200 ratio simply means a large quantity of raw root was processed down into a small quantity of extract, which can just as readily reflect low-quality starting material or aggressive processing that destroys fragile bioactives as it can reflect genuine potency. Physta® itself sits at a ratio of around 1:20 by design — its potency comes from preserving and quantifying the right bioactives, not from headline concentration. The figure to look for on a Tongkat Ali label is the standardised eurycomanone percentage (typically 0.8–1.5%), not the ratio. The same standardisation logic — actives measured and disclosed, not extraction theatre — is the meaningful quality signal across all three herbs.

Singapore as a Premium Consumer Base for the Global Herbal Market

Singapore occupies a uniquely significant position in the global herbal supplement market — one that goes beyond its modest population size. As one of the wealthiest cities in Asia, with a health-conscious, highly educated consumer base that bridges Eastern botanical traditions and Western scientific standards, Singapore functions as a premium proving ground for herbal supplement brands seeking to establish credibility in the broader Asian market.

This position has not gone unnoticed by the industry. Several of the world's most clinically invested herbal extract producers — including Biotropics Malaysia (Physta® Tongkat Ali), Ixoreal Biomed (KSM-66® ashwagandha), and the Korean Ginseng Corporation — have established or significantly expanded their Singapore retail presence over the past five years, recognising that the Singaporean consumer both demands and responds to evidence-based marketing in a way that many other regional markets do not yet.

When a supplement brand succeeds in Singapore, it does so against a consumer base that reads ingredient lists, traces clinical citations, and compares COA documentation — a quality filter that, paradoxically, makes Singapore one of the most reliable indicators of genuine product merit in the region.

Which Herb, and for Whom?

The question of which herb is definitively best for Singaporean men cannot be answered in the singular, and any publication that claims otherwise is oversimplifying a question that the science has deliberately not resolved that way. What the convergence of traditional wisdom and modern clinical evidence does support is a framework in which the best herb is the one most precisely matched to the individual's primary physiological concern.

Primary concern	Best-matched herb	Key mechanism
Hormonal depletion, chronic stress-driven androgen suppression, declining physical vitality	Tongkat Ali (Physta®)	Dual HPA-axis cortisol reduction + HPG-axis testosterone support
Cognitive resilience, immune function, vascular sexual health	Ginseng (Panax)	Ginsenosides; nitric-oxide endothelial pathway
Stress, anxiety, sleep dysfunction, nervous-system overactivation	Ashwagandha (KSM-66®/Sensoril®)	Withanolides; sedative-leaning adaptogenic profile

 

For men whose central challenge is hormonal depletion, chronic stress-driven androgen suppression, and declining physical vitality — the predominant clinical presentation among Singapore's mid-career professional male population — Tongkat Ali's dual cortisol-lowering and testosterone-supporting mechanism, validated across multiple human RCTs using standardised extracts, makes it the most specifically targeted and evidence-supported choice available in the herbal supplement category today.

For cognitive performance and immune resilience, ginseng's multi-century clinical tradition and substantial modern evidence base remain unmatched. For stress and anxiety management with a calming rather than energising quality, ashwagandha's withanolide-driven adaptogenic profile is the most robustly evidenced option.

What is perhaps most extraordinary, when one steps back to consider the full arc from forest floor to clinical trial, is how consistently the modern evidence confirms what the traditional practitioner already knew — and what the Singaporean consumer, bridging both worlds with characteristic pragmatism, is increasingly in a position to act on with genuine intelligence.

Frequently Asked Questions

Which is the best herbal supplement for Singaporean men?

There is no single answer, and any claim otherwise is marketing rather than medicine. For most Singaporean men presenting with the dominant clinical picture — chronic-stress-driven testosterone suppression, fatigue, declining physical drive — Tongkat Ali (Physta® specifically) has the strongest dual-mechanism evidence base. For cognitive performance and vascular sexual health, ginseng is more directly indicated. For stress, anxiety, and sleep, ashwagandha (KSM-66® or Sensoril®) is the most evidenced option. Match the herb to the individual's primary physiological concern, not to the loudest packaging.

Why is Physta® considered the most clinically validated Tongkat Ali extract?

Physta® was developed through a Biotropics Malaysia–FRIM collaboration that built a standardised hot-water extract — defined by its eurycomanone percentage (0.8–1.5%), glycosaponins (>40%), and protein (>22%) — that can be reproducibly tested in human trials. The Talbott 2013, Henkel 2014, and Tambi 2012 randomised controlled trials all used Physta® or comparable standardised material, which is why "Physta®" is the brand that appears in the published literature far more often than any other Tongkat Ali extract.

Does a higher extract ratio (1:100 or 1:200) mean a stronger Tongkat Ali product?

No — extract ratios are largely marketing jargon. A 1:200 ratio simply means a large amount of raw root was processed down to a small amount of extract, which can reflect low-quality starting material or aggressive processing that destroys fragile bioactives as easily as it can reflect potency. Physta®, the most clinically studied standardised Tongkat Ali extract, sits at a ratio of around 1:20 by design. Look for the standardised eurycomanone percentage (0.8–1.5%) on the label, not the ratio.

How much Tongkat Ali should I take, and when?

The evidence-supported daily range for a standardised extract is 200–400 mg, with 200 mg the most-replicated baseline across Physta® RCTs and 400 mg supported by trials in physically active populations. Around 600 mg sits at the upper clinical ceiling for shorter-term cycled use; doses above 600 mg are experimental and lack long-term human data. Three timing windows are evidence-supported: morning (with or without food), about 30 minutes before exercise, or evening (per Toyama et al. 2022, Japanese Pharmacology & Therapeutics, which found improvements in stress markers and sleep quality). The one practical caveat: avoid taking it within an hour or two of bedtime in the first weeks of use while you observe your individual response.

Can I combine Tongkat Ali, ginseng, and ashwagandha?

Combinations are possible and in some clinical pictures are productive. Tongkat Ali + ginseng are mechanistically complementary (androgenic + vascular pathways) and tend to be well-tolerated together. Tongkat Ali + ashwagandha combines an androgenic-supporting herb with a calming adaptogen and is particularly relevant for men with both stress-driven testosterone suppression and anxiety comorbidity. Best practice is to introduce one herb at a time so you can observe each one's individual effect before combining, and to keep doses within the evidenced ranges for each rather than stacking maximums.

Are these herbal supplements safe to take long-term?

For the standardised, properly sourced forms (Physta® Tongkat Ali, KSM-66® or Sensoril® ashwagandha, Korean Red Ginseng, branded maca extracts), the long-term safety profiles in published literature are reassuring. Tongkat Ali specifically has a wide safety margin — oral LD50 of approximately 3,000 mg/kg of body weight for the water-soluble extract in rodents, with even higher tolerance for root powder (>6,000 mg/kg). The real long-term risks in this category are commercial rather than pharmacological: unstandardised products, adulterated supply chains, and dose creep beyond the evidenced range.

References

Benzie, I. F. F., & Wachtel-Galor, S. (Eds.). (2011). Herbal medicine: Biomolecular and clinical aspects (2nd ed.). CRC Press. https://doi.org/10.1201/b10787

Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomised double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. https://doi.org/10.4103/0253-7176.106022

Henkel, R. R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. M. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors: A pilot study. Phytotherapy Research, 28(4), 544–550. https://doi.org/10.1002/ptr.5017

Kennedy, D. O., & Scholey, A. B. (2003). Ginseng: Potential for the enhancement of cognitive performance and mood. Pharmacology, Biochemistry and Behavior, 75(3), 687–700. https://doi.org/10.1016/S0091-3057(03)00126-6

Leisegang, K., Finelli, R., Sikka, S. C., & Iyer, S. (2022). Eurycoma longifolia (Jack) in men's health: A review of its physiological, sexual, and ergogenic properties. Medicines, 9(5), 35. https://doi.org/10.3390/medicines9050035

Rehman, S. U., Choe, K., & Yoo, H. H. (2016). Review on a traditional herbal medicine, Eurycoma longifolia Jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules, 21(3), 331. https://doi.org/10.3390/molecules21030331

Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10(1), 28. https://doi.org/10.1186/1550-2783-10-28

Tambi, M. I. B. M., Imran, M. K., & Henkel, R. R. (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism. Andrologia, 44(Suppl. 1), 226–230. https://doi.org/10.1111/j.1439-0272.2011.01168.x

Toyama, H., Nakagawa, M., Iizuka, K., Kawatake, T., Toyama, T., & Tanaka, M. (2022). Randomized controlled trial of the effects of Tongkat Ali intake on stress markers and sleep quality in healthy Japanese adults. Japanese Pharmacology & Therapeutics, 50(5), 871. https://www.pieronline.jp/content/article/0386-3603/50050/871

World Health Organization. (2019). WHO global report on traditional and complementary medicine 2019. https://www.who.int/publications/i/item/978924151536